This study identified a novel oncogenic VIRMA/IGF2BP1–LINC00839–TAF15–AOC1 axis and highlights the pivotal role and prognostic potential of LINC00839 in NPC progression. Here, VIRMA is linked to nasopharyngeal carcinoma.